Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
22.81
+0.33 (1.47%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fresenius Medical Care AG Revenue
Fresenius Medical Care AG had revenue of 4.76B EUR in the quarter ending September 30, 2024, a decrease of -3.57%. This brings the company's revenue in the last twelve months to 19.24B, down -1.15% year-over-year. In the year 2023, Fresenius Medical Care AG had annual revenue of 19.45B with 0.29% growth.
Revenue (ttm)
19.24B EUR
Revenue Growth
-1.15%
P/S Ratio
n/a
Revenue / Employee
160,532 EUR
Employees
119,845
Market Cap
13.41B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
Dec 31, 2019 | 17.48B | 929.68M | 5.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Viatris | 15.05B |
Avantor | 6.82B |
Incyte | 4.08B |
Dr. Reddy's Laboratories | 3.58B |
Genmab | 2.97B |
Revvity | 2.72B |
Royalty Pharma | 2.27B |
Neurocrine Biosciences | 2.24B |
FMS News
- 1 day ago - Fresenius Medical Care returns to Dax 40 Index - PRNewsWire
- 6 weeks ago - Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024 - PRNewsWire
- 2 months ago - Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024 - PRNewsWire
- 2 months ago - Fresenius Medical Care: Let's Look At The Upside - Seeking Alpha
- 3 months ago - Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software - PRNewsWire
- 5 months ago - Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024 - PRNewsWire